Related references
Note: Only part of the references are listed.Prognostic impact of tumor microvessels in intrahepatic cholangiocarcinoma: association with tumor-infiltrating lymphocytes
Kyohei Yugawa et al.
MODERN PATHOLOGY (2021)
Impact of Immune Response on Outcomes in Hepatocellular Carcinoma: Association With Vascular Formation
Shinji Itoh et al.
HEPATOLOGY (2020)
Prognostic impact of CD8+T cell distribution and its association with the HLA class I expression in intrahepatic cholangiocarcinoma
Yoh Asahi et al.
SURGERY TODAY (2020)
FDG uptake reflects breast cancer immunological features: the PD-L1 expression and degree of TILs in primary breast cancer
Tomoko Hirakata et al.
BREAST CANCER RESEARCH AND TREATMENT (2020)
Diagnostic value of 18F-FDG-PET to predict the tumour immune status defined by tumoural PD-L1 and CD8+tumour-infiltrating lymphocytes in oral squamous cell carcinoma
Maria Togo et al.
BRITISH JOURNAL OF CANCER (2020)
18F-fluorodeoxyglucose positron emission tomography correlates with tumor immunometabolic phenotypes in resected lung cancer
Kyle G. Mitchell et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2020)
Uptake of positron emission tomography tracers reflects the tumor immune status in esophageal squamous cell carcinoma
Kengo Kuriyama et al.
CANCER SCIENCE (2020)
Nonalcoholic Steatohepatitis: A Review
Adam C. Sheka et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
PD-L1 expression correlation with metabolic parameters of FDG PET/CT and clinicopathological characteristics in non-small cell lung cancer
Xiaodong Wu et al.
EJNMMI RESEARCH (2020)
Is sarcopenic obesity superior to sarcopenia as a predicting indicator in patients with hepatocellular carcinoma following hepatic resection?
Shinji Itoh et al.
HEPATOBILIARY SURGERY AND NUTRITION (2020)
Prognostic impact of 8-hydroxy-deoxyguanosine and its repair enzyme 8-hydroxy-deoxyguanosine DNA glycosylase in hepatocellular carcinoma
Kyohei Yugawa et al.
PATHOLOGY INTERNATIONAL (2020)
Diabetes and PKM2 affect prognosis in patients with intrahepatic cholangiocarcinoma
Kui Fu et al.
ONCOLOGY LETTERS (2020)
Impact of body mass index on tumor recurrence among patients undergoing curative-intent resection of intrahepatic cholangiocarcinoma- a multi-institutional international analysis
Katiuscha Merath et al.
EJSO (2019)
Obesity: global epidemiology and pathogenesis
Matthias Blueher
NATURE REVIEWS ENDOCRINOLOGY (2019)
HHLA2 in intrahepatic cholangiocarcinoma: an immune checkpoint with prognostic significance and wider expression compared with PD-L1
Chu-Yu Jing et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Tissue Immune Cells Fuel Obesity-Associated Inflammation in Adipose Tissue and Beyond
Rui Liu et al.
FRONTIERS IN IMMUNOLOGY (2019)
The Clinicopathological and Prognostic Value of PD-L1 Expression in Cholangiocarcinoma: A Meta-Analysis
Gang Xu et al.
FRONTIERS IN ONCOLOGY (2019)
Skeletal muscle mass predicts the prognosis of patients with intrahepatic cholangiocarcinoma
Kyohei Yugawa et al.
AMERICAN JOURNAL OF SURGERY (2019)
Obesity and gastrointestinal cancer: the interrelationship of adipose and tumour microenvironments
Jacintha O'Sullivan et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2018)
Obesity and recurrence-free survival in patients with hepatocellular carcinoma after achieving sustained virological response to interferon therapy for chronic hepatitis C
Hiroji Shinkawa et al.
ANNALS OF GASTROENTEROLOGICAL SURGERY (2018)
Epigenome-wide association study of body mass index, and the adverse outcomes of adiposity
Simone Wahl et al.
NATURE (2017)
Adapting to obesity with adipose tissue inflammation
Shannon M. Reilly et al.
NATURE REVIEWS ENDOCRINOLOGY (2017)
Non-alcoholic fatty liver disease as a risk factor for cholangiocarcinoma: a systematic review and meta-analysis
Nicha Wongjarupong et al.
BMC GASTROENTEROLOGY (2017)
Elevated Metabolic Activity on 18F-FDG PET/CT Is Associated with the Expression of EZH2 in Non-small Cell Lung Cancer
Gouji Toyokawa et al.
ANTICANCER RESEARCH (2017)
Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)
Jesus M. Banales et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2016)
Body Fatness and Cancer - Viewpoint of the IARC Working Group
Beatrice Lauby-Secretan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Intratumoral CD3 and CD8 T-cell Densities Associated with Relapse-Free Survival in HCC
Andrew Gabrielson et al.
CANCER IMMUNOLOGY RESEARCH (2016)
Monitoring therapeutic efficacy of sunitinib using [18F] FDG and [18F] FMISO PET in an immunocompetent model of luminal B (HER2-positive)-type mammary carcinoma
Benoit Theze et al.
BMC CANCER (2015)
Correlation Between Biological Marker Expression and Fluorine-18 Fluorodeoxyglucose Uptake in Hepatocellular Carcinoma
Yohei Mano et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2014)
Cancer Statistics, 2014
Rebecca Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2014)
DNA methylation and body-mass index: a genome-wide analysis
Katherine J. Dick et al.
LANCET (2014)
New scoring system for prediction of microvascular invasion in patients with hepatocellular carcinoma
Ken Shirabe et al.
LIVER INTERNATIONAL (2014)
Safety and Activity of Anti-PD-L1 Antibody in Patients with Advanced Cancer
Julie R. Brahmer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Endpoints and clinical trial design for nonalcoholic steatohepatitis
Arun J. Sanyal et al.
HEPATOLOGY (2011)
The role of 18F-fluorodeoxyglucose positron emission tomography in the diagnosis, staging, and follow-up of cholangiocarcinoma
Chang Mo Moon et al.
SURGICAL ONCOLOGY-OXFORD (2011)
Design and validation of a histological scoring system for nonalcoholic fatty liver disease
DE Kleiner et al.
HEPATOLOGY (2005)
Overweight, obesity, and mortality from cancer in a prospectively studied cohort of US adults
EE Calle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States
T Patel
HEPATOLOGY (2001)
Share Paper
